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ABSTRACT 
 
The prevalence of heart failure became a major and growing public health problem 
globally, with rising mortality numbers causing a great financial burden. In Mongolia, the 
hospitalization for cardiovascular diseases makes up 55% of all hospitalizations, and mortality 
rate of circulatory diseases was the highest nationwide, accounting for 36.7% of all deaths 
(S.Ariuntuya et al., 2011). However, there is still no formal research addressing the prevalence of 
heart failure in Mongolia. Therefore, this paper is meant to bring awareness of the problem of 
hidden heart failure in Mongolia, which might be contributing significantly to the cardiovascular 
disease mortality and health care costs. This paper describes the Mongolian health care structure 
and the high incidence of heart failure risk factors is identified. Moreover, this paper proposes to 
develop and adapt a heart failure disease management program, as well as the heart failure 
patient education program in Mongolia. It is important that Mongolian health care providers and 
health policy makers acknowledge that if a proper disease management plan is not adapted soon, 
the prevalence of heart failure will continue to increase along with health care costs. Mongolia 
needs more public health and clinical researchers addressing heart failure.               
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CHAPTER I: LITERATURE REVIEW 
Cardiovascular Disease and Heart Failure in the United States and globally 
Cardiovascular diseases (CVDs) are one of the biggest public health problems around the 
world, accounting for almost half of chronic or non-communicable diseases (NCDs). The NCDs 
have overtaken the prevalence of infectious diseases, and have become the major disease burden 
in most countries. The CVDs are a large public health issue with a very high rate of morbidity 
and mortality.  According to the World Health Organization (WHO), CVDs account for 17.3 
million deaths per year, and this number is expected to grow to >23.6 million by 2030 (“WHO | 
Global atlas on cardiovascular disease prevention and control,” n.d.).    
According to Roger et al. (2012), around 5.7 million people in the United States (US) 
have heart failure (HF) and it was the primary cause of more than 280,000 deaths (1 in 9) in 
2008. The overall mortality rate attributed to CVDs was 244.8 per 10,000,000; and is still 
responsible for 32.8% (811,940) of all deaths in 2008. Even though the morbidity of HF is a 
serious public health problem in the US, the mortality of CVDs has decreased since 1968, which 
was the peak of CVD mortality in the US. A decline in CVD mortality was made possible due to 
a decrease of the major cardiovascular risk factors of tobacco, high cholesterol and blood 
pressure in the US population. In addition, the innovation of evidence-based treatments of CVDs 
made an even larger contribution to the decline in CVD prevalence (Ford et al., 2007). 
Studies in the US (1980-1990) confirmed that the decline of the main risk factors lowered 
CVD mortality by 50%, and overall mortality in coronary disease patients by 70% (Hunink et al., 
1997).  Another study stated that more than half of the decline in ischemic heart disease 
mortality during 1968-1976 was related to changes of lifestyle and behavior (Goldman & Cook, 
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1984).  Recently it was discovered that the rate of death related to CVDs in the US from 1998 to 
2008 declined by 30% (Roger et al., 2012).  
Not surprisingly, not only the US has been able to decrease CVD mortality, but other 
high industrialized countries have managed to do so as well.  These decreases range from 44%-
76% and included reductions in mortality in countries such as Finland (Vartiainen, Puska, 
Pekkanen, Tuomilehto, & Jousilahti, 1994 & Laatikainen et al., 2005), the Netherlands (Bots & 
Grobbee, 1996), Scotland (Capewell, Morrison, & McMurray, 1999), New Zealand (Capewell, 
Beaglehole, Seddon, & McMurray, 2000 & Beaglehole 1986), England (Unal, Critchley, & 
Capewell, 2004),  and Wales (Unal, Critchley, & Capewell, 2005). 
Cardiovascular Disease and Heart Failure in developing countries 
According to the WHO, 80% of total CVDs mortality occurs in low and middle income 
countries.  Sufferers of CVD in these countries often have shorter life spans compared to their 
peers (Smith Jr et al., 2012).  A major cardiovascular cause of death is heart failure (HF).  HF is 
a medical condition that decreases ability of heart to pump blood and circulate it throughout the 
body.  The CVDs and HF are even more difficult to manage with limited resources and few 
evidence based programs, making the consequences of CVD mortality much more devastating in 
developing countries.  As such, people with CVDs and HF in low and middle income countries 
die younger due to poor health interventions, lack of education and health literacy, and financial 
restrains.  
Non-Communicable Diseases (NCDs), especially CVDs and Heart Failure (HF), are 
more threatening than they may seem, and also place a huge economic burden on countries 
around the world.  Due to the chronic nature and complications of NCDs, they are long lasting, 
deteriorating medical conditions that require multiple interventions and continuous health care. 
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From 2011 to 2025, the estimated financial losses from all NCDs are $7.28 trillion in low and 
middle income countries. CVDs alone account for about 50% of this projected loss. But if low 
and middle income countries were able to reduce CVD mortality by 10%, it would result in a 
$377 billion reduction of financial losses from 2011 to 2025 (“WHO | From burden to ‘best 
buys’,” n.d., 2013).            
HF may seriously damage developing countries by creating loss of productivity of 
cardiac patients. It often severely limits a person’s ability to work.  Loss of productivity hurts not 
only the individual, but affects the family’s income and the country itself by extension.  Also, the 
weakened cardiac patients often need care givers; consequently, a care giver often is a family 
member and he or she has to stop working in order to nurse a cardiac patient at home.  To treat 
HF and maintain good health in cardiac patients, it is necessary to prescribe several medicines 
that can be difficult to afford for some people. For the majority of middle and low income 
families in developing countries, the symptoms of poor health, financial burden, and loss of 
productivity may result in devastating consequences, which may lead to uncertainty about the 
family’s future.        
Sadly, globalization creates unforeseen problems for most middle and low income 
countries.  Adaption of the westernized lifestyle and poor diet of developed countries is 
spreading worldwide.  Limited financial resources and poor structure of health care systems in 
developing countries creates a barrier in managing the impending global epidemic of chronic 
diseases.  The need for adapting evidence based treatment plans and exemplary public health 
approaches from successful experiences of other countries should be urgent priorities for middle 
and low income countries. 
Cardiovascular Disease and Heart Failure in Mongolia 
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It is important to support and help to improve CVDs and HF disease management 
programs in developing countries.  Mongolia is a developing country that is in a transitional 
period from low to middle income country during the past few years.  It is considered one of the 
fastest developing countries today because of the recent mining boom and export of mineral 
resources such as coal, copper, and gold.  The recent increase in financial resources is creating an 
enormous opportunity for Mongolians to redevelop outdated internal structures and improve 
existing systems. The health care sector is one of the fields that needs reform. This paper 
includes the essential parts of the Mongolian health care system, which will allow the reader to 
understand its future challenges and strengths.  This paper intends to build awareness among 
Mongolian physicians and health related officials to strive for health care growth and reform.  
The limited number of public health surveillance systems in Mongolia makes it difficult 
to address the prevalence or mortality rate of a specific disease, such as HF. The complete lack 
of HF data was what brought my attention to this global public health problem.  However, there 
were data available about leading risk factors for HF and data for morbidity and mortality rates 
of CVDs. Not surprisingly, levels of HF risk factors and CVDs in Mongolia are very high.  Even 
though the prevalence, incidence and mortality of HF were unknown, there was enough data to 
support that idea that HF prevalence in Mongolia may be a large and increasing problem. 
Therefore, it is important for Mongolians to promote evidence-based HF disease management 
approaches, approved by the American Heart Association (AHA) and the Heart Failure Society 
of America (HFSA). The Mongolian healthcare system has not yet adapted standards of patient 
education. Neither physician nor nurses are provided with specific training on proper patient 
education.  Therefore a large portion of this paper provides evidence-based methods of HF 
patient education.  
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Based on the current public health data and financial burden of HF, this paper addresses 
possible improvements that can be done in HF disease management and patient education in 
Mongolia. It is important to adapt the core of evidence-based HF disease management program. 
This paper will highlight especially the HF patient education approaches which do not require 
any structural change and are easily adaptable.  
Heart Failure risk factors  
Unfortunately the HF prevalence, incidence, and mortality rate data is not yet available in 
Mongolia. There was no data found that specifically addressed HF in Mongolia.  Nevertheless, 
the research addressing the CVDs and HF’s main risk factors were found in the report 
“Mongolian Health Indicator 2011.”  There is major scientific consensus regarding the positive 
association of several risk factors with HF, and this section will address those factors.  Even 
though HF data is not available, it is important to use available information to address this public 
health problem in Mongolia.   
HF is a broadly investigated disease because of its burdens. There are numerous studies 
that prove HF prevalence is positively associated with several risk factors. The very first research 
that addressed the etiology of this disease was the cohort study that followed individuals for 20 
years, the Framingham Heart Study in the 1970s.  According to the Framingham Heart Study, 
HF had several main risk factors. The greatest population attributable risk factor for HF was 
determined to be hypertension, accounting for 39% of HF cases in men and 59% in women. The 
second greatest attributable risk factor was myocardial infarction, accounting for 34% of HF in 
men, and 13% in women.  Other important risk factors identified were diabetes mellitus, left 
ventricular hypertrophy and valvular heart disease (Ho, Pinsky, Kannel, & Levy, 1993). This was 
the first scientific evidence of HF being associated with behavioral factors.  
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Another large cohort study was done by first National Health and Nutrition Examination 
Survey Epidemiologic Follow-up Study (NHANES I), it was also initiated in the 1970s. The 
cohort study stated that HFs largest independent risk factor was coronary artery disease. In 
addition, there were other attributable risks such as hypertension, smoking, physical inactivity, 
overweight, obesity, low educational level, diabetes, and valvular heart disease(He et al., 2001).  
Other studies showed similar results, confirming HF’s association with the above mentioned 
health conditions, lifestyle choices and behaviors: the main risk factors for CVDs are 
hypertension, valvular disease, alcohol consumption, tobacco use, diabetes mellitus, dilated 
cardiomyopathy and systemic heart diseases(Andersson & Waagstein, 1993) (William B. 
Kannel, 2000). 
The causes of HF in elderly and middle aged adults are very similar, except in elderly 
people HF is more likely to be multifactorial due to greater likelihood of having several long 
term chronic factors.  Certainly the process of aging alone is a strong influencing factor for the 
development of HF in elderly population.  Much of the increased risk is due to lowered immune 
system defense, slower metabolism, and weaker natural physiological functions of the body, 
making the elderly more vulnerable.  In old people the coronary diseases and hypertension 
account for more than 70% of CVD cases, making them perfect candidates for HF (William B. 
Kannel, 2000). This association of HF with old age is one of the key factors that makes HF a 
very difficult disease to manage.       
Even though diabetes was selected as one of the risk factors in Framingham Heart Study, 
recent studies have shown that diabetes is more influential in contributing to the development of 
HF than originally believed.  Diabetic patients report much higher incidence of HF, accounting 
for a rate of 31 per 1000 persons a year (Nichols, Gullion, Koro, Ephross, & Brown, 2004), 
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compared to the Framingham studies’ value  of 9-14 cases per 1000 diabetic women (Ho et al., 
1993).  The latest studies showed much higher incidence of HF in diabetic patients and not only 
in females, but in both genders even when age and ethnicity are controlled for. According to the 
Heart and Estrogen/progestin Replacement Study (NERS), diabetes was the greatest independent 
risk factor for the development of HF and coronary artery disease with an adjusted hazard ratio 
of 3.1 (95% CI:2.3 to 4.2)(Bibbins-Domingo et al., 2004).  
Globally, obesity is definitely one of the most concerning risk factors for CVDs and other 
medical conditions.  Overweight and obesity are measured by the body mass index method 
(BMI, kg/m
2
).  In the Framingham Heart Study of 5 881 participants, high BMI levels associated 
with the development of HF by 5% for men and 7% for women(Kenchaiah et al., 2002).  A 
recent prospective cohort study confirmed the positive association of obesity/overweight and HF, 
with a larger population of 21 094 men. This study stated that the overweight people (BMI 25-
29.9 kg/m
2) and obese people (BMI ≥30 kg/m2) were directly and independently associated with 
increased risk of developing HF, with an adjusted relative risk compared to lean people (BMI < 
25kg/m
2
) of 1.49 (95% CI: 1.32-1.69) and 2.80 (95% CI: 2.24-3.50)(Kenchaiah, Sesso, & 
Gaziano, 2009). In addition, not only was the level of BMI was associated with HF, but engaging 
in physical activity or neglecting to also was associated with HF. The physically inactive, obese 
men had a higher risk of HF (3.9, 95% CI: 2.6-6.0), and physically inactive overweight men also 
had a higher risk of HF (1.8, 95% CI: 1.4-2.2), compared to men who were lean and physically 
active. In addition, physically active obese men (2.7, 95% CI: 2.1-3.5), and physically active 
overweight men (1.595%, CI: 1.3-1.7), both still had higher relative risks of HF than lean active 
men (Kenchaiah et al., 2009). From this study, researchers learned that level of BMI is strongly 
associated with incidence of HF, as is the level of physical activity of people.  
8 
 
It has been proven that lowering risk factors would eventually decrease the probability of 
developing HF. The majority of HF incidents (90%) are attributable to risk factors such as 
diabetes, obesity, smoking, blood pressure, and high cholesterol (Folsom, Yamagishi, Hozawa, 
& Chambless, 2009).  By lowering BMI, stopping smoking, keeping cholesterol and blood 
pressure low, and staying away from other mentioned risk factors, people could potentially be 
protected from HF, CVDs and other chronic diseases.  Knowing risk factors is very important for 
HF incidence prevention, but they can also be used in controlling HF and CVD disease. 
Therefore, knowing the prevalence of HF risk factors allows for estimating the prevalence of HF 
in Mongolia.       
It is important to address HF in Mongolia because of the high prevalence of its risk 
factors.  By avoiding these risk factors, average middle age adults are able to decrease HF events 
by approximately 77% (Folsom, Yamagishi, Hozawa, & Chambless, 2009). Based on this 
information, Mongolian public health preventive efforts should be directed towards young adults 
who currently have these risk factors. Community efforts to spread preventive health education 
and policies supporting to decrease risk factors are urgently needed.            
In order to get a sense of HF, CVDs, and other public health issues in Mongolia, I believe 
it is useful to briefly introduce the Mongolian Health Care System and its structures.  Due to the 
limited public health surveillance data, specifically HF, the below section references the 
Mongolian government annual report “The Health Indicator 2011” (S.Ariuntuya et al., 2011). 
This review will suggest that the Mongolia’s rural demographic patterns, fragmented health care, 
and increased prevalence of risk factors make HF a major but preventable cause of death and 
preventable financial burden on the health care system in a long run.       
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CHAPTER II: HEALTH SYSTEM AND HEART FAILURE RISK 
FACTORS IN MONGOLIA 
Mongolian health system 
Mongolia is located between Russia and China. It covers 1 567 000 km
3, 
and the 
population reached 2.8 million in 2011. The average life expectancy is 64.68 years in men and 
73.76 years in women.  Mongolia is divided into 21 aimags (states). Aimags are further divided 
into a total of 329 sums, which are similar to districts. The capital is Ulaanbaatar city; in 2011, 
the population of Ulaanbaatar reached 1.26 million, which is 67.07% of the country’s total 
population (Graph 1.). Households residing in urban area have increased by 61.3%, while in rural 
areas decreased by 4.3% compared to the year 2000. This data supports the increasing migration 
to the capital city due to socioeconomic differences and availability of jobs, thus creating large 
health disparities between Mongolians.   
Graph 1. 2011 mid-year population divided in aimags (Health Indicator Mongolia 2011)       
Aimags (States) 
Number of population 
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Rural health care  
Sum health centers are the first line of healthcare in the countryside. The number of 
health providers and diversity of health services varies depending on population density and 
geographical location.  Rural citizens may also receive health care in the 37 units of intersum 
hospitals (hospitals between districts). Unfortunately, many rural hospitals don’t meet the 
national health care standards due to lack of professional preparedness and lack of medical 
technology.  If countryside hospitals are not able to deliver needed care, patients are referred to 
the capital.    
District and Aimag hospitals 
There are 8 district urban hospitals and 17 aimag hospitals (state hospitals). Beside 
physicians and nurses there are 1,027 health care workers who are people trained by the 
government to assist in health promotion and prevention.  Their roles are not very clear, but they 
would be perfect candidates to perform home visits for HF patients. The bed occupancy in these 
hospitals is increasing rapidly due to the centralization of population in urban centers and 
increasing prevalence of chronic diseases.  
Urban health care 
The increasing trend of overpopulation in the capital is directly associated with the rising 
demand for healthcare services. In the Ulaanbaatar (UB) city the number of outpatient visits 
from 2005 to 2011 increased from 3 million to 4.1 million visits per year. The number of medical 
examinations per visit in Ulaanbaatar, 8198.4, was far greater than in the visits in rural sums, 
1740.  This difference shows shifting health demand and supply rural to urban areas (Graph 2.).      
Family health care centers and primary care 
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As of 2011, there were 219 family health care centers (urban), and 274 sum (rural 
districts) health centers providing primary health care. These urban family health care centers are 
privately owned organization contracted by the government to deliver primary health care to the 
urban community established in 2002.  124 units provide medical care and public health services 
to the citizens of the capital city, Ulaanbaatar. In 2011, family health care centers provided health 
services for 5.9 million outpatient visits, with an average of 3.2 visits per year per person (Graph 
2.). Of those visits, health preventive examinations made up 42% of family health care centers in 
Ulaanbaatar, and 31.8% in rural aimag centers.  
Graph 2. Total number of outpatient visits to family health care centers in 2011 (Health 
Indicator Mongolia 2011) 
 
Private hospitals 
The size and other specific details of the general hospitals depend on the present demand 
and needs of the society in that region. Most of the privately owned hospitals are located in the 
capital, and have the best medical equipment and a better inpatient environment compared to 
government hospitals. But due to the limited number of highly trained doctors in Mongolia, 
efficient human resource planning is a tough challenge for the private sector.     
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Central hospitals 
In Mongolia there are 6 central hospitals providing the third tier of care. Central hospitals 
have highly skilled doctors, providing the broadest range of medical attention in Mongolia. 
These hospitals receive 21.1% of total hospital beds and admit approximately 19.8% of 
inpatients from the national total admissions. The problem is there are always many more 
patients heading to the third tier hospitals because patients are not satisfied with the service 
provided in the primary care. The system of referral does not work efficiently, because third 
level hospitals provide variety of outpatient services for fee. The ill patients prefer to go to the 
third tier hospitals, where they will be attended by a highly trained specialist with experience. 
From the total number of 134,000 patients admitted to the central hospitals, 25.2% of them were 
referred from lower tier. Even though there was an increase of referrals from lower level 
hospitals by 13.1% compared to 2009, it still shows the system of hospital and patient 
administration and referrals needs to be improved. 
Inpatient  length of stay and payments 
The 2011 health indicator report showed the average length of stay in a district general 
hospital was 7.9 days per patient. The average length of stay in aimag general hospitals was 8.1 
day per patient. In addition, the length of stay in the capital’s third level general hospitals was 10 
days (Table 1.), which was greater than both district and aimag hospitals. The average 10 days of 
inpatients in Mongolia is very high compared to the US hospital’s average length of stay which 
is 4.8 days (“Surveys and Data Collection Systems Homepage,” n.d.).  The reason for the 
prolonged average length of inpatient stay is the inadequate payment system. According to the 
health care laws, the patient pays only a portion of total inpatient medical care expenses, with a 
fixed amount of payment for all inpatient stay. The payment mechanism leads to inadequate 
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information about the care received in the hospital; such knowledge could be crucial for 
designing the HF program. The rest of the payments are covered by government national health 
insurance, and the government.  
Table 1. Central hospital and specialized care centers accessibility and quality indicators 
(Health Indicator Mongolia 2011) 
 
In addition, Mongolian hospitals don’t have an appropriate patient discharge process. 
After treating patients at hospitals, health providers do not provide formal patient education, 
neither patient discharge sheet. The current discharge process consists mainly of brief chat with 
the health provider. The physicians answer the patient’s questions, and give recommendations 
orally. Without being provided formal patient education nor written educational material and 
discharge sheet, patients often leave the hospital without an appropriate understanding of the 
disease and their expected behavior. Therefore, the development of formal patient discharge 
system can improve significantly the patient outcome.      
Heart Failure risk factors in Mongolia  
By analyzing the prevalence of risk factors of HF in Mongolia, it allows us to deduce that 
heart failure is prevalent despite a lack of official data. The following section discusses the 
alarming rates of HF risk factors in Mongolia such as: tobacco use, alcohol use, low 
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consumption of fruits and vegetables, low physical activity, air pollution, diabetes, hypertension 
and ischemic heart disease.   
Tobacco  
According to the Health Indicator Mongolia 2011, since 2005 the prevalence of tobacco 
users increased from 25.9% to 27.6%. According to “The Tobacco Atlas, 2012,” written by Prof. 
Michael Eriksen, 40-49.9% of Mongolian men are smokers; 40-59.9% of youth live in homes 
where others smoke in their presence; and 70-75.9% of male teenagers (ages 13-15) consume 
cigarettes (Eriksen, Mackay, & Ross, 2012). Unfortunately, the prevalence of chronic smokers 
among men is very high and a new generation of teenagers is quickly adapting this habit.        
Alcohol 
The regular use of alcohol increased from 30.5% in 2005 to 38.60% in 2009. According 
to Alessandro R. D. (2013), 50% of men and 30% of women were found to be current drinkers of 
alcohol (Demaio et al., 2013).  Due to the increasing stress produced by socio economic factors 
and unemployment in the community, alcohol consumption is very high among adults and it is 
rapidly increasing among teenagers. Unfortunately, in Mongolia most leaders of the alcohol 
industries have strong connections in the high level politics and the Mongolian parliament, which 
makes it more difficult to fight against alcohol abuse.      
Consumption of fruits and vegetables 
Mongolian weather does not allow growing different types of fruits and vegetables, 
because of the extreme cold (-40’C or -40’F) winter and hot (+37’C or 99’F) summer seasons. 
Therefore an average Mongolian consumes fewer fresh fruits and green vegetables, but more 
meat and flour compared to citizens from developed countries. The recorded intake of fruits by 
the national survey showed would Mongolians consume fruit on only 1.6 days of the week in 
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2005, and this amount was reduced to 1.2 days of the week in 2009. The prevalence of people 
who consume more than two servings of vegetables per day accounted for 44.4% of population 
in 2005, and decreased to 29.7% in 2009. An unhealthy diet is positively associated with the 
prevalence of obesity, diabetes, and other NCDs. This allows us to assume that low consumption 
of fruits and vegetable is contributing to the prevalence of HF in Mongolia.     
Physical activity 
People with active lifestyles who exercised on a regular basis (30 mins minimum per 
day), accounted for 15.4% of the population in 2005, and this number decreased to 11.7% of the 
total population in 2009. I found it impractical to try to estimate an average amount of physical 
activity for Mongolians because of the life style differences in urban and rural areas. Most 
herders and other people from rural areas live in a completely rural environment and are 
involved in much more daily physical activity than urban residents, such as carrying drinking 
water from local wells, and preparing fire wood for cooking purposes. The urban residents have 
adapted the westernized sedentary life style. Therefore, the average of the above mentioned two 
lifestyles would not be an accurate description of the average physical activity of an average 
Mongolian. Therefore, this topic is highly recommended for further research in the future. 
Nevertheless, the available data estimated that in 15.4% of Mongolians in 2005 and 11.7% of 
Mongolians in 2009, average physical activity is low and on the decline, thus becoming a major 
risk factor for HF and other NCDs.       
Obesity 
Researchers reporting the prevalence of obesity, abdominal obesity and body fat among 
408 Mongolian adults aged 25 years and above, included 61.2% from urban areas and 38.8% 
from rural areas. According to the results, about one-third (32.8%) of the subjects were 
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overweight and 10.5% obese. In addition, the prevalence of abdominal obesity was found to be 
46.5%  in the men and in 65.1% of the women.  The author stated that Mongolian adults face a 
serious risk of cardiovascular diseases and other health issues because of the high rate of obesity 
(Otgontuya, Khor, Lye, & Norhaizan, 2009). 
Diabetes  
According to the available data, diabetes accounted for 0.6% of all reported cases of non-
communicable diseases in Mongolia. The incidence rate of diabetes was 36.7 per 10,000 
population, which increased by7.3 per 10,000 compared to the previous year (29.4 in 2010), with 
minimal difference in gender.  The population of 45-65 years olds with diabetes increased to 
23.6 cases in one year, reaching 141.4 cases per 10,000. The rural area population showed the 
lowest prevalence of diabetes by 5.9 cases, but diabetes incidence was the highest in rural areas. 
Thus diabetes mellitus is a becoming a major public health problem in rural and urban Mongolia, 
with an incidence of 10,222 cases in 2011.  It is important to remember that the prevalence of 
diabetes is directly associated with the prevalence of HF (Ho et al., 1993).     
Hypertension and ischemic disease  
Hypertension makes up 3.8% of all non-communicable diseases in Mongolia. The 
incidence rate was 311.8 cases per 10,000 populations. The data supported that the incidence in 
rural areas was higher than in urban areas by 278.2 cases.  In 2011, the number of new CVD 
cases diagnosed reached 209,550 cases and accounted for 6,291 deaths. Hypertension accounted 
for the largest incidence with 15,726 cases, and 444 deaths. The second largest disease was 
ischemic heart disease with 47,906 cases, which accounted for 1,620 deaths. Other cases 
included rheumatic fever and rheumatic heart diseases, cerebrovascular diseases, and acute 
myocardial infarctions. The available CVD data proves that circulatory diseases are one of major 
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health issues in Mongolia, and that HF should be addressed as a potential major contributor to 
this rising public health problem in Mongolia.            
Cardiovascular diseases in Mongolia  
As of 2011, the circulatory diseases were the fourth most common non-communicable 
disease in Mongolia. The prevalence of cardiovascular system diseases accounted for 752.07 
cases per 10,000 populations in Mongolia, and is still increasing (Graph 3.). From the nationwide 
hospital inpatient health service data, cardiovascular diseases were found to be the second 
leading causes of morbidity that were treated at hospitals.  
 
Graph 3. Five leading causes of morbidity in Mongolia, per 10,000 population /2001-
2011/ (Mongolian Health Indicator 2011) 
 
CVDs are one of the five leading causes of hospitalizations since 2000. The most 
common causes of hospitalization are hypertension (34.7%) and ischemic heart disease (19.2%). 
In 2011, the inpatient prevalence of hypertension increased to 36.8% and ischemic heart diseases 
increased to 26%.   
18 
 
CVDs mortality rate 
Since 1995, the three leading causes of death in Mongolia have been cardiovascular 
diseases, neoplasms and injuries. In Mongolia, circulatory system diseases are the number one 
cause of all mortality in both sexes. CVD alone accounted for 36.7% of all deaths. CVD is an 
alarming public health issue in Mongolia, the number of deaths due to CVD is almost as much as 
the number of the cancer and injuries combined.  An average of 6000-6500 people (or one third 
of total mortality) die due to CVD. The seniors 65 years of age and older were the most affected 
age group, and adults aged 45-65 years were the next high age group for CVD mortality in 
Mongolia. In 2011, 17,124 deaths were registered nationwide, which was an increase by 143 
cases or 0.9% from the last year’s statistics. 24.5% of total deaths or 4,176, occurred in hospitals, 
of which 26% occurred within 24 hours of admission.  
Even though there is lack of data on the specific cause of CVD mortality in hospitals, HF 
is a potential major cause of mortality and a major attributor to the CVDs morbidity. Due to its 
potential burden on the society and health care finance, HF should be further investigated 
extensively. The above mentioned health conditions and potential risk factors are major issues of 
the past and present of Mongolia. The alarming level of mortality of CVDs should encourage 
Mongolians to adapt better approaches of disease treatment, management, and prevention 
programs. The morbidity and mortality of CVDs are rising, but HF is not addressed at all in any 
existing literature in Mongolia. Therefore, HF must be investigated, and Mongolian health policy 
makers are strongly encouraged to develop an evidence-based approach to deal with this global 
public health issue.    
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CHAPTER III: PROPOSED HEART FAILURE DISEASE 
MANAGEMENT IN MONGOLIA 
Evidence on Heart Failure disease management program 
HF disease management programs can reduce hospitalizations and improve patient’s 
quality of life. This supposition is supported by numerous studies demonstrating the 
effectiveness of disease management programs in terms of positive outcomes for HF patients in 
the US and other countries.  
Health education and patient’s self-management support will not only bring a significant 
improvement to a patient’s quality of life, but they are one of the most cost effective ways to deal 
with this situation. For HF patients it is very common to improve significantly in the hospital 
under doctor’s supervision, but after being discharged their health deteriorates and re-
hospitalization is very common.  HF changes a patient’s daily lifestyle and it is difficult for them 
to comply with a doctor’s recommendations, especially without any support. Therefore, patient’s 
self-management support is an important factor that correlates with the success of HF 
management.            
A large study was conducted at the American Veterans Affairs medical center to prove 
the effectiveness of HF disease management programs in large populations. There 969 veterans 
with HF in total; 458 received the HF program (intervention group) and 511 received the usual 
care (control). The intervention group showed significantly fewer (p<0.05) HF complications 
and fewer all cause admissions at one year follow up, and lower mortality through the 2 year 
follow up (Lowery et al., 2012).  Another US study with 88 HF patients (44 in intervention and 
44 in control) also reported patient improvement in a HF disease management program with a 
39% decrease in total number of readmissions (Krumholz et al., 2002). The intervention group 
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showed significantly lower risk of readmission compared with the control group (hazard ratio = 
0.56, 95% CI: 0.32, 0.96; p = 0.03). Krumholz concluded that providing health education and 
supporting HF disease programs significantly reduces the adverse clinical outcomes and cost for 
HF patients.   
Australian researchers also agree with the benefits of HF disease management programs. 
Steward, Simon, and Horowitz (2002) conducted a 4.2 years cohort study (N=297) that focused 
on the effectiveness of home based HF interventions. Results confirmed that home based 
interventions had 78 fewer unplanned readmissions compared to usual care (0.17 compared 0.29 
readmissions per patient per month; p<0.05); the median cost for intervention patient was $325 
compared to usual care patient $660 per month(Simon Stewart & Horowitz, 2002).   
In Ireland, researchers also conducted a study comparing two groups of HF patients. In 
the first group patients received inpatient and outpatient education sessions with telephone calls 
or clinic follow up, but second group received the usual care. The results not surprisingly were 
similar to the previous HF researchers from other countries. At 3 months after discharge from the 
first group four people had events (7.8% rate) compared to the second group with only 12 people 
(25.5% rate) , with P=0.04. This data showed that HF disease management program is positively 
associated with lower risk of HF complications after being discharged (McDonald et al., 2002).  
Some authors estimate that 50% of emergency department patients with HF could be 
safely discharged after a brief period of observation, avoiding unnecessary admissions and 
minimizing readmissions (Collins et al., 2013). Creating observational unit management may be 
ideal for low risk and intermediate risk patients with HF that require only symptomatic 
treatment(Collins et al., 2010). According to Collins, most patients are most often admitted 
because of the uncertainty regarding post discharge events, therefore, large number of these 
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admissions could be avoided yet patients could still receive timely and effective care. If HF 
patients come to the emergency department because of failure to control symptoms of the 
disease, the HF patient must be provided with HF disease instructions and education specifically 
designed for the average educated person.    
According to the Heart Failure Society of America (HFSA) (Lindenfeld et al., 2010), the 
modifiable factors leading to hospital readmissions for HF are: 
- Inadequate patient and family or caregiver education and counseling 
- Poor communication and coordination of care among health care providers 
- Inadequate discharge planning 
- Failure to organize adequate follow-up care 
- Clinician failure to emphasize non pharmacologic aspects of HF care, such as dietary, 
activity, and symptom monitoring recommendations 
- Failure to address the multiple and complex medical, behavioral, psychosocial, 
environmental, and financial issues that complicate care, such as older age, presence of 
multiple comorbidities, lack of social support or social isolation, failure of existing social 
support systems, functional or cognitive impairments, poverty, presence of anxiety or 
depression 
- Failure of clinicians to use evidence-based practice and follow published guidelines in the 
prescription of pharmacologic and non-pharmacologic therapy 
 
In summary, the main components of HF programs shown to be effective are:  
 Developing a HF multidisciplinary team 
 Improving health worker’s decision making 
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 Developing inpatient and outpatient education session and material 
 Providing patient discharge instructions 
 Improving patient’s health access 
 Monitoring HF patients after hospital discharge. 
Proposed Heart Failure disease management program in Mongolia  
It is known that adapting HF disease management program improve patient’s health, 
decreases post-discharge complications, and reduces patient’s health cost. Many countries and 
hospitals have developed their own versions of HF programs, and many patients benefit from 
these programs. Unfortunately, the current approach of treating HF in Mongolia does not involve 
evidence based formal disease management programs for HF. Currently, the focus is on 
improving clinical symptoms during the hospitalization period and providing short term 
pharmaceutical therapies, rather than improving post discharge outcomes.       
Therefore, I am proposing to develop a HF disease management program in Mongolia. 
The proposed HF program is expected to improve the quality of patient’s care, decrease HF 
readmissions, reduce the HF patient’s cost, lower HF (CVDs) mortality, improve hospital care, 
increase health education, and support patient’s self-management. The effectiveness of HF 
disease management program greatly depends on the use of evidence based approaches, 
facilitation of culturally acceptable and feasible methodologies, science-based self-care 
behaviors, and effectiveness of the health care system. The health literacy level, lifestyle, beliefs 
and local culture are important factors to consider. Therefore, the HF disease management 
program increases adherence to both pharmacological and non-pharmacological approaches to 
control HF symptoms after hospital discharge. 
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Recommendations for Heart Failure patient education and self-management  
The patient and family members perform the majority of HF care at home. Understanding 
the importance of every prescribed medicinal and behavioral recommendation is important. If the 
individual fails to understand, or doesn’t clearly see what is required and for what reason, he/she 
will fail to self-manage HF. Proper patient education can help patients to better self-manage after 
hospital discharge. That is why comprehensive education and counseling are the essential for HF 
management. The goal of HF education is to help patients and family members to acquire 
appropriate knowledge, skills, strategies, problem solving abilities and motivation. The best 
source of recommendations is found from the Heart Failure Society of America (HFSA). See 
Table 2.       
Table 2. Essential Elements of Patient Education with Associated Skills and Target 
Behaviors (HFSA 2010 Comprehensive Heart Failure Practice Guideline.) 
Elements of education  Skill building and critical target behaviors 
Definition of HF (linking disease, 
symptoms, and treatment) and cause 
of patient’s HF 
- Discuss basic HF information, cause of patient’s 
HF, and how symptoms relate to HF status 
Recognition of escalating symptoms 
and concrete plan for response to 
particular symptoms 
- Identify specific signs and symptoms (eg, 
increasing fatigue or shortness of breath with 
usual activities, dyspnea at rest, nocturnal 
dyspnea or orthopnea, edema) 
- Perform daily weights and know how to respond 
to evidence of volume overload 
24 
 
- Develop action plan for how and when to notify 
the provider, changes to make in diet, fluid and 
diuretics 
Indications and use of each 
medication 
- Reiterate medication dosing schedule, basic 
reason for specific medications, and what to do if 
a dose is missed 
Modify risks for HF progression - Smoking cessation 
- Maintain blood pressure in target range 
- Maintain normal HgA1c, if diabetic 
- Maintain specific body weight 
Specific diet recommendations: 
individualized low-sodium diet; 
recommendation for alcohol intake 
- Understand and comply with sodium restriction 
- Demonstrate how to read a food label to check 
sodium amount per serving and sort foods into 
high- and low-sodium groups 
- Reiterate limits for alcohol consumption or need 
for abstinence if history of alcohol abuse 
Specific activity/exercise 
recommendations 
- Comply with prescribed exercise 
Importance of treatment adherence 
and behavioral strategies to promote 
- Plan and use a medication system that promotes 
routine adherence 
- Plan for refills 
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Self-management 
According to the HF guidelines developed by Heart Failure Society of America (HFSA), 
self-care is an important part of HF management, which involves active participation of the HF 
patient and family members or care giver. It can be seen  two different ways: health maintenance 
and health management (Lindenfeld et al., 2010). Health maintenance includes: 
 Healthy life style decisions (e.g. exercising, maintaining a normal body weight and etc...) 
 Treatment adherence and management (e.g. monitoring weight changes, limiting dietary 
sodium, taking prescribed medications, getting routine immunizations and etc…) 
Self-care management is a cognitive process that allows patients to recognize signs and 
symptoms, evaluate their importance, implement a self-care treatment strategy, and evaluate the 
effectiveness. Lack of knowledge about HF and its methods/strategies to better self-manage can 
lead to a lack of adherence to a prescribed treatment plan, making HF patients more vulnerable 
to deterioration of their health condition. The HF health education is a critical component of HF 
disease management programs.  
The HF guideline of HFSA also emphasizes developing a patient’s skill for self-
management, because knowledge alone is not sufficient. Those skills include the ability to read 
food labels, adapt preferred food to low sodium versions, choose low sodium food options from 
stores, prepare food with little or no sodium, track sodium intake, and choose a low sodium meal 
at restaurants. Other necessary skills are medication adherence, symptom management skills 
(ability to monitor and recognize significant change in signs or symptoms and control with 
appropriate treatment strategy), and self-directed diuretics scheme for managing significant 
increases in body weight (Lindenfeld et al., 2010).     
The American Heart Association (AHA) clarified that several behavioral patterns are 
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most important in self-management, these are: adherence to prescribed medication, diet and 
exercise, symptoms and weight monitoring, fluid and alcohol restrictions, smoking cessation, 
informing the doctor of any other non-prescribed medication they have taken including 
complimentary therapies, and incorporating preventable behaviors in their lifestyle such as 
regular dental care (Riegel et al., 2009).   The above mentioned recommendations from AHA 
were developed to ensure success in a HF patient’s self-management and decision making. 
Patient adherence to a doctor’s recommendation is difficult to enforce because of certain barriers. 
Riegel and Carlson (2002) discovered that those barriers consist of lack of understanding of HF 
and its symptoms, complex treatment regimes, and limitation in undertaking activities of daily 
living and emotional wellbeing (Barbara Riegel & Carlson, 2002). The participants of this study 
acknowledged that the biggest problem was that they don’t have a sufficient understanding about 
HF. However, Carlson, Riegel, and Moser (2001) found that individuals with HF improve their 
knowledge of the disease and self-management through experience.  The experience of being ill 
and having to go through multiple HF interventions certainly  aids patients in learning more 
about their medical condition and better self-care methods. These results also showed that the 
health education was provided poorly and inefficiently. 
Patient education 
The educational sessions should begin with an assessment of the patient’s current HF 
knowledge, focusing on issues that the patient is interested in learning, as well as their barriers. 
Each patient needs individualized counseling and education planning based on their prior 
knowledge and experience by providing feedback and reinforcement.  
Besides common barriers, it is important to consider the patient’s readiness to change. 
Health education is effective only if the individual finds the information important. Once the 
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patient finds health education useful, only then he/she may decide to actively participate 
according to the treatment plan. But many patients are not ready to change their behavior 
suddenly. According to one of the many existing models, patients can be divided in 4 phases 
(Prochaska, DiClemente, & Norcross, 1992):  
1. Pre-contemplation: patients don’t consider change at all 
2. Contemplation: patients think about change but yet to make a commitment  
3. Preparation: patients plan to change in the future and may have already engaged in some 
early steps of change  
4.  Maintenance: patients are changing (in action) or are maintaining their change for 6 
months or more  
Health providers should keep in mind that increasing a patient’s motivation is the most 
promising method to influence patient’s decisions. This method is effective from the earliest 
stage to the active stage of change. Specific techniques and different emphases are needed in 
education planning depending on patient readiness and stages of change (Saarmann, Daugherty, 
& Riegel, 2000).  For example, education provided to patients considering a change will be most 
effective if they receive more information about their health condition. But patients who are in 
the contemplation stage have enough information and find more information irritating; yet, they 
might respond to education where potential benefits are emphasized. Patients who are in the 
preparation stage would respond to the comments and feedback that increase their level of 
confidence, focusing on techniques to build their self-management ability. The health education 
method of approach and emphasized topics is most effective if patients get individual assessment 
and delivery technique.                 
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Health providers also should keep in mind that provoking fear and coercion result in 
inefficiency. Research showed that if people feel pushed for to change it causes personal 
resistance to not change, even if it is for their own sake (Saarmann et al., 2000). Similar 
approaches, such as dictating decisions to patients or making decisions on behalf of them, are 
rarely considered effective in the long term because personal reasoning and ownership over 
his/her decisions are essential (Lindenfeld et al., 2010). 
The HFSA recommends that the frequency and intensity of HF education and counseling 
vary according to the patient’s health condition. Patients with advanced HF or with persistent 
difficulty in adhering to recommendations require more education and counseling compared to 
others. Surprisingly, the researchers found that when patients with few symptoms, or less 
complicated HF, received intensive counseling they show negative outcomes in terms of use of 
health resource, cost, and quality of life (B Riegel, Carlson, Glaser, & Hoagland, 2000). Patients 
with severe HF conditions have the most benefit from intensive and frequent educational 
sessions.  The educational planning is important; during the acute care hospitalization only the 
essential HF information should be provided. The goal is to aid patients in understanding HF, the 
goal of the patient’s treatment, the post hospitalization medication, recommendations and follow 
up regimen. The education started during the hospitalization period should be enriched and 
provided again within 1-2 weeks after discharge, and continued for 3-6 months (Lindenfeld et 
al., 2010).   
Including family members in the HF patient’s health education is very important. The 
need to change his/her traditional lifestyle and physical limitations are the biggest reasons for 
depression and stress.  Mental and emotional state can directly contribute to the HF patient’s 
health outcome and self-management. Providing health education to family members allows 
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them to learn of the patient’s condition, helping to create a supportive and stress free 
environment at home. Cognitive impairment, functional disabilities, multiple comorbidities and 
other conditions may limit their ability to fully comprehend, appreciate, or enact what they learn 
(Moser & Watkins, 2008). Creating a positive, stress free environment at HF patient’s residence 
is important.       
According to Clark and Lan (2004), patients found that HF signature symptoms were the 
most important information to learn. Because the appearance of certain symptoms allowed 
patients to realize their health deterioration and allowed precautionary actions to be taken, in 
some cases even preventing death. In addition, the evidence showed that the symptoms of HF are 
more important to learn than information about diet control, physical activity, and other 
psychological topics (J. C. Clark & Lan, 2004). Patients were more concerned in knowing what 
to steps to follow when their health deteriorates, rather than knowing the prevention of HF 
symptoms. Therefore, Mongolian health educators are encouraged to develop contents covering 
the patient’s personal interests and it is very important allow them to show their personal 
concerns.   
The HF patient’s education about prescribed pharmaceutical medications are considered 
one of the most critical pieces of information. It is essential for patients to understand the 
function of the medication rather than just memorizing names and dose. HF patients need to 
understand that medications such as beta-blockers and angiotensin converting enzymes inhibitors 
are prescribed to control blood pressure, but not to “keep their heart from failing.” If a patient 
doesn’t fully comprehend the reasons why these medications were prescribed, for instance, he or 
she may take a beta blocker even when their blood pressure is low, failing to understand that it 
was prescribed to lower the high blood pressure. Therefore, health educators must clearly 
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communicate the purpose of prescribed medicines, allowing patients to familiarize themselves 
with each prescribed medicine.  
Other evidence suggests that motivated patients can learn and change their behavior 
significantly by receiving distance counseling such as telephone calls, mail, or through other 
technology; but this effectiveness was negated in those with cognitive impairment, depression, 
low literacy level, poor social support, and low socio-economic status (Strömberg, Ahlén, 
Fridlund, & Dahlström, 2002). Therefore, health providers should keep in mind evaluating every 
HF patient to determine which educational approach would be most beneficial and affordable on 
an individual basis. But regardless of what method is used, it is encouraged to cover the 
educational material in more than one way (e.g. verbal with written materials).    
Patient knowledge test 
After providing health education it is important to test patient’s knowledge. To make sure 
that the educational session is effective, health providers are recommended to ask patients to 
demonstrate their knowledge about: 
 The name, dose and purpose of each medication 
 Be able to sort foods into high and low sodium categories 
 Demonstrate their preferred method for tracking medication dosing 
 Show the provider a daily weight log; repeat symptoms of worsening HF 
 Knowing when to call the health provider because of specific symptoms or weight 
changes 
The patient’s knowledge test is important because health provider’s time and effort in 
patient education should be evaluated for effectiveness. Providing health education is effectively 
delivering needed information. It is important to make sure that the patients have fully 
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comprehended the provided materials, and patients should feel confident to implement these 
recommendations. The best way to confirm patient’s knowledge is by asking the patients verbal 
and written questions and also by asking patients to demonstrate what they have understood. 
This allows patients to fully comprehend and retain the HF information. Adapting the 
questionnaire session into the HF education planning may take additional time for health 
providers; but without this session the effectiveness of provided education is questionable. In 
addition, it would help patients to retain the newly acquired knowledge, and patients may 
experience additional benefit from the health educational program.       
Finally, HF patients often find themselves with restrictions that limit daily activities. The 
most difficult restriction was changing diet, because this is one of the few pleasures left after 
being diagnosed with HF. That is why it is very difficult for patients to comply with dietary 
restrictions. Therefore, health providers should attempt suggesting creative solutions on how to 
maintain their dietary compliance, rather than just providing facts and restrictions. Due to the 
fact that fruits and vegetables are very expensive in Mongolia, the health providers and educators 
are advised to put more focus on the dairy products. Mongolians have more ability to increase 
the consumption of dairy products, because in Mongolia there are still a great number of herders 
that produce numerous traditional dairy products from their cattle.           
Proposed HF education delivery system  
A hospital’s environment and patient’s emotional state can influence the patient’s 
education efficiency. In the hospital’s environment it is difficult to learn and retain any new 
information because patient’s and family member’s minds are more likely to be worrying and 
anxious (Horan et al., 2000). There were studies that showed that 46% of patients were not 
compliant after recent discharge, particularly demonstrating low accuracy in medication related 
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knowledge (S Stewart & Pearson, 1999). Another study found that half of all patients 
interviewed said that they didn’t receive any medication related education before discharge; 70% 
claimed that they didn’t receive written materials; and only 43% were able to name their 
prescribed medications. No one knew side effects of their prescribed medications (Alibhai, Han, 
& Naglie, 1999).  Lessons learned from this research were that the medication regimen aspect of 
health education must be confirmed by patient’s responses, and health education should be 
reinforced and additional teaching started within one week of discharge.  In addition, health 
education and counseling should be undertaken as a systematic educational approach that 
continues for 3-6 months according to the needs of the patient and family (Barbara Riegel et al., 
2002).     
To implement a HF disease management program and HF patient education it is 
important to form HF multidisciplinary teams within departments. The team should consist of 
trained HF physicians, nurses and other health workers. Forming HF teams allow patients to 
receive the best care, provide more efficient education, help them in self-management and 
prevent re-hospitalizations. Training physicians allow them to be better prepared in managing 
HF patients, and develop up to date, evidence-based individual patient treatment plans. The 
effectiveness of the program directly depends on HF physician’s preparation.  It is also important 
to train nurses to become specialized “HF nurses” because they are the front line health 
providers, working closely with patients on a daily basis. The HF nurses act accord to each 
patient’s individual treatment plan guided by HF clinicians. In order to ensure the efficiency of 
the HF team work, it is highly advised to have HF “champion” nurses (or clinicians): leader 
nurses (clinicians) who volunteer to become HF nurses (clinicians) and show other nurses 
(clinicians) exemplary HF care. The spectrum of responsibilities of HF nurses would range from 
33 
 
prevention, palliation and health education, depending on the patient’s condition. Other health 
related workers can be part of the team: HF pharmacists are recommended; their role is 
important especially in providing options for pharmaceutical treatment plans and ensuring the 
most appropriate choices depending on the patient’s personal concerns. In Mongolia including 
pharmacists is encouraged, but not necessary. The pharmacists lack a legal environment to 
prescribe medicines. Because pharmacists don’t need to prescribe medications, patients are not 
required to bring prescriptions to buy any medicine from pharmacies. Therefore, a pharmacist’s 
role may not be received seriously by patients and also some health providers.  
In addition, the evidence shows that the HF patients and their family members should 
receive individualized education and counseling delivered by nurses and supplemented by 
physicians. Even though HF nurses deliver the health education and the patient’s knowledge is 
tested, HF clinicians are encouraged to approach patients for any doubts that they may have. 
Depending on the availability, the contributions of nutritionists, health workers, and other health 
volunteers are encouraged for extra health education after being discharged.  It is also known that 
teaching is not sufficient without skill building and counseling after hospital discharge. The 
Mongolian health workers and volunteers may contribute greatly in helping patients in self- 
management and continuing HF education at home. 
The availability of patient’s medical history is important, but in Mongolia it can be a 
challenge. Globally, the most preferable method of information sharing has become electronic 
medical record (EMR) systems in hospitals. But unfortunately these are expensive systems 
Mongolia cannot yet afford.  Currently, Mongolian doctors use the traditional method of a 
patient’s personal clinical history hand written on paper, which is carried by the patient every 
time he/she sees a doctor. The most commonly encountered problem with this type of medical 
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history is the difficulty of maintaining a complete medical history over a long period, including 
the loss of medical records or keeping more than one. As a consequence, doctors often have to 
rely on oral medical history provided by the patient or his/her family. The bad hand writing of 
different physicians is also a problem, making it difficult to read for others.  Lack of commonly 
followed standards on patient’s medical visits is also an issue. As a consequence, there is a 
possibility of incomplete information provided from one visit to the next. Therefore, I am 
proposing to develop a standard writing scheme for HF patients, with well-structured 
information about their medical condition and previous visits. Standardization of HF patient’s 
medical history writing order may help physicians to provide more specific and effective 
treatment plan.       
Providing discharge instructions to patients and family members is very important. Even 
though discharge instructions can be very different, here is one example. These discharge 
instructions were originally taken from that Grady Memorial Hospital’s version, and was adapted 
with some changes.  
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CHAPTER IV: CONCLUSION 
The implementation plan in Mongolia  
Currently there are many issues with the Mongolian health care system addressed in 
previous sections.  From all of those problems, I chose this topic because it seemed most feasible 
to implement in Mongolia. Because of an existing personal contact with Mongolian cardiologists 
at the 1
st
 central hospital in Ulaanbaatar, I will be able to implement the primary version of this 
HF disease management program and patient education in the Cardiology department. Local 
stakeholders are hospital management and leader cardiologists. They have showed their interest 
in implementing this evidence-based disease management plan and patient education. After 
further discussing with key stakeholders and champion cardiologists, we agreed to develop the 
most efficient and feasible model that can be adapted easily in Mongolian hospitals and further 
throughout the health care system.  
In addition to applying this program in the “1st central hospital”, my plan is to do research 
based on pre and post intervention data accumulated from the hospital’s patient’s data archive. 
This will hopefully discover the effects of this program by comparing pre and post HF patient re-
hospitalization data. The key measures would focus on improvements of re-hospitalization and 
patient’s quality of life triggered by the implementation of this program. In case of positive 
associations in the results of this program, we will have an opportunity to publish findings and 
propose it to the stakeholders at the Health of Ministry of Mongolia. If the program shows 
promising results we would partner with the Ministry and hopefully apply this program to other 
health care centers and hospitals, making it a part of national NCDs management program in the 
future. 
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Challenges 
The possible challenges in implementation of this program are: lack of some local 
physician’s support, health care workers refusing to adapt the new approach, Mongolian 
geological characteristics, discrepancy of urban and rural areas, the inefficient health care 
system, gaps in socioeconomic status, inequality in patient’s education, and limited health care 
access.    
The current traditional health system will be a huge barrier in adapting similar programs. 
Inefficient payment system, low salary of physicians, and lack of transparency in the hospitals’ 
environments will delay people striving for adapting new disease management programs at 
hospitals.  In addition, local health providers might not agree with the proposed plan and refuse 
to participate in such innovative changes. Hopefully, support of hospital administration, 
champion doctors, and nurses will help this program to advance and be adapted successfully in 
health care settings of Mongolia. However, it is evident that the Mongolian health care system is 
no longer functioning effectively for neither for health workers nor the people therefore I 
strongly encourage health care reform when the timing is right.            
The discrepancy existing between the rural and urban areas in Mongolia is large. It 
includes the discrepancies in: monthly earning, health access, education, economic, social and 
environmental factors.  Because of these large gaps in discrepancies, this program will face some 
barriers in adapting this kind of programs. Nevertheless, an improvement of primary care access 
is necessary; the content of evidence-based proper health education packages must be developed 
and provided to HF patients regardless. 
Clark et al. (2007) observed low obedience to doctor’s HF guidelines, issues with 
diagnostics, and issues with the implementation of interventions in rural communities compared 
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to urban areas.  It is evident that in rural areas with limited health care access and health 
discrepancies, it is much more difficult to provide efficient care to HF patients and to support 
self-management after discharge. Therefore, the HF disease management program and proper 
health education standards must be developed and applied in practice in Mongolia as soon as 
possible. 
The health educational sessions should be developed on individual basis, depending on 
the patient’s literacy level, cognitive status, psychological state, culture, and access to social and 
financial resources. Patients should be screened for cognitive impairment and depression, 
because these can interfere with learning. Even though low literacy is not a problem for 
Mongolians, the discrepancy in social, economic and environmental factors is very large. Health 
providers should keep in mind that physical, cognitive, social, and environmental factors can 
affect the efficiency of educational sessions. Cognitive impairment is the most prevalent problem 
in HF patients and can affect significantly the patient’s ability to learn and retain information 
(Bennett & Sauvé, 2003 & Zuccalà et al., 2003).  
Another well-known barrier to HF disease management program is depression, and it is 
astrong predictor of mortality for HF patients. According to an article written by Tiny Jaarsma, 
identification of depressive symptoms before enrollment in a disease management program 
might lead more effective use of the program because depressive patients might not benefit from 
a general program (Jaarsma et al., 2010). Unfortunately, the treatment for depression seems not 
to improve outcomes; therefore, patients with cognitive impairment and depression need more 
support and assistance of family member or caregivers at home (Lindenfeld et al., 2010). The 
depression and cognitive impairment is often encountered in low socio-economic areas; this 
might become a barrier for those HF patients who live in rural or lower income districts of 
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Mongolia. Putting more resources towards and providing more assistance for this group of 
people will be a challenge for a country with limited resources.       
HF patients often encounter several barriers that are the main reasons of patient’s 
unsuccessful self-management. Health providers should keep in mind that barriers in medication 
adherence are: high medication cost, transportation to the pharmacy or health clinics and 
confusion among prescribed drugs (S Stewart & Pearson, 1999). Barriers on sodium restriction 
adherence include time, cost, taste, others not eating low sodium food, interference with social-
cultural norms or traditional food options, difficulty changing diet habits and etc… (Happ, 
Naylor, & Roe-Prior, 1997)                
Conclusion 
This paper discussed numerous evidences that support preventing and reducing 
mortality/morbidity of HF, CVDs and NCDs around the world, and especially in Mongolia. It is 
important for Mongolian health policy makers and health providers to be aware of patient needs 
and rising public health problems in Mongolia. Changing the entire health care system and 
developing totally different mechanisms to the ongoing system is not feasible today. It is 
important to look for the feasibility of any program or change. Therefore I believe that the most 
cost effective and feasible approach is to adopt an evidence-based HF disease management and 
patient education program in the health delivery system in Mongolia. All the interventions from 
the disease management program target the behavioral change and the elimination of risk factors 
that have been directly associated with the heart conditions. They also focus on delivering the 
necessary knowledge about a patient’s own health condition; making sure that they understand 
that it is a part of the treatment plan. Development of a disease management program might be a 
challenge, but it is a necessary change that many Mongolians need. The HF management 
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program promotes patient’s self-management and self-management tools. It is difficult for a 
patient to deal with HF alone, and if some habits are not corrected HF patient lifespans will be 
shortened significantly, their quality of life drops, and health care cost will rise greatly. In 
conclusion, this paper is written to bring awareness among Mongolian health professionals and 
health policy makers about this hidden and very serious public health problem in Mongolia. In 
addition, I am proposing to develop and exercise the most appropriate, culturally adaptable and 
efficient HF disease management program and patient education in Mongolia, particularly in 
hospital settings.  
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